Sacral Nerve Stimulation Trial Phase

Sacral Nerve Stimulation Trial Phase

The Sacral Nerve Stimulation Trial Phase allows patients to evaluate symptom improvement before proceeding to permanent implantation. This sacral nerve stimulation trial procedure generally lasts approximately 2 weeks and uses a temporary sacral nerve electrode connected to an external stimulation device.
Send Inquiry
Description
Technical Parameters

The Sacral Nerve Stimulation Trial Phase allows patients to evaluate symptom improvement before proceeding to permanent implantation. This sacral nerve stimulation trial procedure generally lasts approximately 2 weeks and uses a temporary sacral nerve electrode connected to an external stimulation device. According to the published treatment pathway, symptom improvement of 50% or more is the threshold for considering the second-stage procedure.

Trial Stimulation Procedure

The sacral neuromodulation trial procedure begins with percutaneous placement of a temporary electrode near the sacral nerve.

The procedure described in the treatment information includes:

  • Local anesthesia is administered.
  • A temporary electrode is inserted percutaneously near the sacral nerve.
  • The electrode is connected to an external stimulation device.
  • The patient uses the external device during the trial period.
  • Symptoms are monitored and evaluated to assess the treatment response.

The procedure is described as taking approximately 1 hour. Local anesthesia is used, and general anesthesia is not required according to the published treatment information.

Patient Selection and Assessment

Sacral nerve stimulation may be considered for patients with persistent symptoms associated with the following conditions:

  • Refractory overactive bladder
  • Urge urinary incontinence
  • Non-obstructive urinary retention
  • Neurogenic bladder
  • Fecal incontinence
  • Refractory constipation
  • Chronic pelvic pain syndrome

Patient suitability must be determined through clinical assessment. Relevant considerations include symptoms, medical history, previous treatments and overall clinical condition. Having one of these conditions does not automatically establish eligibility for trial stimulation.

Trial Results and Treatment Decisions

The trial result determines whether the patient may proceed to permanent implantation.

Successful trial: 50% or greater symptom improvement

According to the published treatment pathway, patients meeting this threshold may be considered for the second stage. The temporary electrode is replaced with a permanent electrode, and the pulse generator is placed under the skin.

Unsuccessful trial: Less than 50% symptom improvement

The temporary electrode is removed, and permanent implantation does not proceed through this trial pathway.

The published information also indicates an interval of approximately 2–4 weeks between the trial and permanent implantation. This interval is distinct from the approximately 2-week trial period. The final treatment decision and timing depend on clinical evaluation.

Trial Configuration and Clinical Support

The sacral nerve stimulation trial configuration described in the treatment pathway is as follows:

Component or requirement Trial-stage configuration
Electrode Temporary sacral nerve electrode
Placement method Percutaneous insertion
Anesthesia Local anesthesia
Stimulation equipment External stimulator
Trial duration Approximately 2 weeks
Evaluation threshold 50% or greater symptom improvement
Next-stage option Permanent implantation following successful evaluation

The temporary electrode and external stimulator are used during the evaluation stage. Permanent implantation involves a different configuration, including a permanent electrode and a pulse generator placed under the skin.

International Patient Support

The available international patient support information covers several stages of medical coordination:

  • Medical record review: Review of existing medical records before travel.
  • Remote assessment: Written medical assessment based on the patient's available clinical information. The published service information indicates a response within 1–3 working days.
  • Treatment coordination: Assistance with medical consultation and treatment arrangements in China.
  • Communication support: English-language communication assistance.
  • Follow-up support: Coordination concerning subsequent care and remote device programming after the patient returns home.

Clinical eligibility, treatment recommendations and procedural decisions remain subject to assessment by the responsible medical professionals.

Request a Medical Assessment

If you are considering the Sacral Nerve Stimulation Trial Phase, submit your existing medical records, diagnosis, symptom history and previous treatment information for an initial review.

Include relevant examination reports and treatment records already available. The medical team can use this information to understand your clinical background and assess whether further evaluation for sacral neuromodulation is appropriate.

Contact us with your available medical records to discuss the trial stimulation procedure, clinical assessment and possible next steps.

 

Hot Tags: sacral nerve stimulation trial phase, China, price, pricelist, quotation, cost, Bladder pacemaker, Bowel dysfunction, clinician programmer neurostimulator, Decrease in pelvic pain severity, Indications For Sacral Neuromodulation, Stage one electrode trial for sacral neuromodulation

Send Inquiry
Send Inquiry